November 24, 2014 Setria Glutathione is now available after Australias Therapeutics Goods Administration (TGA) approved it for use as a therapeutically active ingredient in adults. Glutathione was approved and listed within the Therapeutic Goods (Listing) Notice 2014 (No
Serving Size: 1 Softgel Capsule Amount Per Serving %DV BioGlute proprietary blend 375 mg * of glutathione and essential phospholipids providing Setria glutathione 250 mg * Phospholipid complex 125 mg *
As long as metabolic pathways are under systemic control and well-concerted together, adaptive mechanisms become triggered increasing systemic protection, activating antioxidant defense and repair machinery
2116-A ULTRASOUND-DERIVED FAT FRACTION (UDFF) AND AUTO-POINT SHEAR WAVE (AUTO-PSWE) ON THE DEEP ABDOMINAL TRANSDUCER (DAX) FOR LIVER FAT QUANTIFICATION AND LIVER FIBROSIS ASSESSMENT - A PROSPECTIVE BIOPSY-CONTROLLED STUDY Georg Semmler 1 , Larissa Nixdorf 2 , Lukas Hartl 1 , Michael Schwarz 3 , Lorenz Balcar 1 , Mathias Jachs 3 , Paula Richwien 2 , Magdalena Mairinger 2 , Daniel M Felsenreich 4 , Benedikt Simbrunner 5 , Julia Jedamzik 2 , Lisa Gensthaler 4 , Felix B Langer 4 , Mattias Mandorfer 5 , Thomas Reiberger 6 , Gerhard Prager 2 and David Josef Maria Bauer 3 , (1)Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria, (2)Department of General Surgery, Division of Visceral Surgery, Medical University of Vienna, Vienna, Austria, (3)Medical University of Vienna, (4)Medical Univesity of Vienna, (5)Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, (6)Cemm Research Center for Molecular Medicine of the Austrian Academy of Sciences Background: Ultrasound-derived fat fraction (UDFF) and auto-point shear wave (Auto-pSWE), have emerged as novel techniques for liver steatosis and fibrosis quantification
